Chronic lymphocytic leukemia (CLL): New insight on the pathogenesis of CLL cell survival

被引:0
|
作者
Lagneaux, L [1 ]
Delforge, A [1 ]
Dejeneffe, M [1 ]
Massy, M [1 ]
Bernier, M [1 ]
Bron, D [1 ]
机构
[1] Inst Jules Bordet, B-1000 Brussels, Belgium
来源
7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION | 2002年
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SDF-1, a CXC-chemokine produced by bone marrow, plays an important role in B-lymphocyte development and trafficking. In this study, we investigated the role of SDF-1 and its receptor, CXCR4, in the chemotactic interaction between CLL cells and bone marrow stromal cells (SC). We observed that CLL cells express surface CXCR4 and migrated in response to recombinant SDF-1. By ELISA, we demonstrated that SC obtained from CLL patients produced significantly more SDF-1 than normal SC leading to increased migration and accumulation of leukemic cells.
引用
收藏
页码:193 / 198
页数:6
相关论文
共 50 条
  • [21] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Oluwatobi Odetola
    Shuo Ma
    Current Hematologic Malignancy Reports, 2023, 18 : 130 - 143
  • [22] The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies
    Burger, Jan A.
    Gribben, John G.
    SEMINARS IN CANCER BIOLOGY, 2014, 24 : 71 - 81
  • [23] BLAST CRISIS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    RAHMAN, F
    CLINICAL RESEARCH, 1976, 24 (03): : A317 - A317
  • [24] The proteome landscape of Chronic Lymphocytic Leukemia (CLL)
    Meier-Abt, F.
    Lu, J.
    Nanni, P.
    Collins, B.
    Xue, P.
    Gwerder, M.
    Roiss, M.
    Huellein, J.
    Oakes, C.
    Dietrich, S.
    Huber, W.
    Aebersold, R.
    Zenz, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 69 - 70
  • [25] Advances in the treatment of chronic lymphocytic leukemia (CLL)
    Lechner, K
    Jager, U
    Geissler, K
    Greinix, H
    Kalhs, P
    WIENER KLINISCHE WOCHENSCHRIFT, 1998, 110 (20) : 701 - 708
  • [26] Novel Agents in Chronic Lymphocytic Leukemia (CLL)
    Danilov, Alexey V.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S30 - S31
  • [27] IMMUNE THROMBOCYTOPENIA IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    KADEN, BR
    HAUCH, TW
    ROSSE, WF
    CLINICAL RESEARCH, 1977, 25 (03): : A408 - A408
  • [28] Conventional cytogenetics in chronic lymphocytic leukemia (CLL)
    Rocha, Cristiano Krings
    Wendtner, Clemens Martin
    Hallek, Michael
    Kreuzer, Karl-Anton
    LEUKEMIA RESEARCH, 2011, 35 (03) : E25 - E25
  • [29] Molecular genetics in chronic lymphocytic leukemia (CLL)
    Chena, C
    Pedrazzini, E
    Sarmiento, M
    Arrosagaray, G
    Bengio, R
    Slavutsky, I
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 66 - 66
  • [30] Targeted Therapy in Chronic Lymphocytic Leukemia (CLL)
    Pettijohn, Erin M.
    Ma, Shuo
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2017, 12 (01) : 20 - 28